– SA, Johannesburg – Thungela Resources Limited (JSE: TGA | LON: TGA) today announced the appointment of Yoza Jekwa to its Board as an Independent Non-Executive Director, effective from 12 August 2022.
Yoza will also join the Thungela Social and Ethics Committee.
The board of directors welcomes Yoza and looks forward to the knowledge and experience that she will contribute to the group.
About Yoza Noluyolo Jekwa
Yoza is the CEO and Co-founder of Thrive Capital Partners (an investment firm focused on infrastructure and impact investing in SA and other parts of Sub-Saharan Africa. Before establishing Thrive Capital Partners, Yoza was the CEO of Mergence Investment Managers, a mid-sized diversified asset management company with products in the listed and unlisted space, with circa R35 billion of Assets Under Management. She also has extensive investment banking experience as an originator and structurer of acquisition financing/ investments for mid to large-cap corporates in South Africa, Sub-Saharan Africa, and Europe, as a dealmaker within RMB, and as a Principal in Acquisition and Leverage Finance at Nedbank. Yoza currently serves as an independent non-executive director on the board of Brait PLC. She is also an independent non-executive director on the board of Northam Platinum, and a member of its HR, Social Ethics and Transformation Committee, Audit and Risk Committee, and its Occupational Health and Safety Committee. She is a former independent non-executive director and Chair of the Investment Committee at Ascendis Health Limited. Yoza is actively involved in various outreach and social responsibility programs.
For more information: https://www.thungela.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
